Yes, I did notice that. Apparently, they're going for a more dramatic return in the medical field, presumably to offset the higher risk. As I said, there's very little not to like about this company, other than it's being rather "strange" to Americans and other folks who don't have a sense of the culture they're working in. Nothing wrong with a little "strange" once in a while, as long as it's discreet. I hope she "love me long time."
Anyway, I'm pretty happy so far.
Market Data 
Markets 
